TOF
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
17 Nov 2023
17 Nov 2023
Historique:
received:
12
01
2023
accepted:
18
10
2023
medline:
27
11
2023
pubmed:
18
11
2023
entrez:
18
11
2023
Statut:
epublish
Résumé
T cell recognition of human leukocyte antigen (HLA)-presented tumor-associated peptides is central for cancer immune surveillance. Mass spectrometry (MS)-based immunopeptidomics represents the only unbiased method for the direct identification and characterization of naturally presented tumor-associated peptides, a key prerequisite for the development of T cell-based immunotherapies. This study reports on the implementation of ion mobility separation-based time-of-flight (TOF
Identifiants
pubmed: 37978195
doi: 10.1038/s41467-023-42692-7
pii: 10.1038/s41467-023-42692-7
pmc: PMC10656517
doi:
Substances chimiques
Histocompatibility Antigens Class I
0
Antigens, Neoplasm
0
HLA Antigens
0
Peptides
0
Histocompatibility Antigens Class II
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7472Informations de copyright
© 2023. The Author(s).
Références
Mol Cell Proteomics. 2007 Jan;6(1):102-13
pubmed: 17074750
ACS Nano. 2021 Oct 26;15(10):15992-16010
pubmed: 34605646
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951
pubmed: 29093164
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
BMC Bioinformatics. 2006 Mar 17;7:153
pubmed: 16545123
Nat Commun. 2016 Nov 21;7:13404
pubmed: 27869121
Elife. 2022 Mar 22;11:
pubmed: 35314027
Hum Immunol. 1985 Mar;12(3):165-76
pubmed: 3872291
Mol Cell Proteomics. 2021;20:100110
pubmed: 34129939
Mol Cell Proteomics. 2021;20:100138
pubmed: 34416385
Expert Rev Proteomics. 2012 Oct;9(5):505-17
pubmed: 23194268
Cell Rep. 2018 Apr 3;23(1):227-238.e3
pubmed: 29617662
Anal Chem. 2020 Jul 7;92(13):9194-9204
pubmed: 32502341
Nucleic Acids Res. 2018 Jan 4;46(D1):D1237-D1247
pubmed: 28985418
BMC Genomics. 2008 Oct 16;9:488
pubmed: 18925949
Methods Mol Biol. 2007;409:75-93
pubmed: 18449993
Commun Biol. 2022 Aug 18;5(1):831
pubmed: 35982173
Cancers (Basel). 2022 Apr 30;14(9):
pubmed: 35565389
Blood. 2019 Feb 7;133(6):550-565
pubmed: 30530751
J Exp Med. 2008 Mar 17;205(3):595-610
pubmed: 18299400
Mol Cell Proteomics. 2018 Mar;17(3):533-548
pubmed: 29242379
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Immunology. 2023 Mar;168(3):420-431
pubmed: 36111495
Mol Cell Proteomics. 2021;20:100022
pubmed: 33583769
Front Immunol. 2022 Apr 06;13:883989
pubmed: 35464395
Nature. 2014 Nov 27;515(7528):572-6
pubmed: 25428506
Anal Chem. 2020 Oct 6;92(19):13084-13091
pubmed: 32668145
J Proteome Res. 2015 Dec 4;14(12):5378-87
pubmed: 26538118
Nat Commun. 2022 Oct 27;13(1):6401
pubmed: 36302754
Methods Mol Biol. 2019;1988:123-136
pubmed: 31147937
Cancers (Basel). 2020 Jun 23;12(6):
pubmed: 32585818
Mol Cell Proteomics. 2021;20:100133
pubmed: 34391888
Nat Commun. 2020 Jan 16;11(1):331
pubmed: 31949144
Immunology. 2018 Jul;154(3):331-345
pubmed: 29658117
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Proteomics. 2018 Jun;18(12):e1700464
pubmed: 29377634
Front Immunol. 2021 Jul 08;12:705974
pubmed: 34305947
Science. 2017 May 26;356(6340):
pubmed: 28495876
Cancers (Basel). 2020 Feb 26;12(3):
pubmed: 32110973
Nat Cancer. 2023 May;4(5):608-628
pubmed: 37127787
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
Cell. 1978 May;14(1):9-20
pubmed: 667938
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E166-75
pubmed: 25548167
Nat Commun. 2021 Feb 19;12(1):1185
pubmed: 33608539
IEEE Trans Vis Comput Graph. 2014 Dec;20(12):1983-92
pubmed: 26356912
Mol Cell Proteomics. 2018 Dec;17(12):2534-2545
pubmed: 30385480
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33858848
J Hepatol. 2016 Oct;65(4):849-855
pubmed: 27397612
Science. 2016 Mar 25;351(6280):1463-9
pubmed: 26940869
Cancers (Basel). 2022 Sep 25;14(19):
pubmed: 36230581
Nat Biotechnol. 2023 Jul;41(7):980-992
pubmed: 36593401
J Clin Oncol. 2013 Nov 10;31(32):e439-42
pubmed: 24043743
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):498-504
pubmed: 15701833
Cancer Cell. 2019 Feb 11;35(2):329
pubmed: 30753829
Front Immunol. 2022 Sep 13;13:932252
pubmed: 36177046
Mol Cell Proteomics. 2014 Aug;13(8):2056-71
pubmed: 24623587
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Mol Cell Proteomics. 2020 Apr;19(4):716-729
pubmed: 32051234
Blood Cancer J. 2020 Feb 28;10(2):24
pubmed: 32111817
Immunity. 2017 Aug 15;47(2):203-208
pubmed: 28813649
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1754-62
pubmed: 25831525
Br J Haematol. 1982 Nov;52(3):411-20
pubmed: 6957244
Mol Cancer Ther. 2017 Nov;16(11):2598-2608
pubmed: 28835386
PLoS Comput Biol. 2013 Oct;9(10):e1003266
pubmed: 24204222